Table 6

Helicobacter pylori eradication with triple therapy (ranitidine bismuth citrate-clarithromycin-metronidazole) according to susceptibility or resistance to both antibiotics

ReferenceType of studyType of treatmentOverallEradication rate
Metronidazole susceptibleMetronidazole resistant
Clarithromycin resistantClarithromycin susceptibleClarithromycin resistantClarithromycin susceptible
RBC, ranitidine bismuth citrate; C, clarithromycin; M, metronidazole.
Bardhan116RandomisedRBC-CM97.6% (41/42)0100% (32/32)0/1100% (9/9)
Savarino115RandomisedRBC-CM97.2% (35/36)2/2100% (17/17)66% (2/3)100% (14/14)
Sung117RandomisedRBC-CM92.8% (52/56)1/191.3% (21/23)0/196.7% 30/31
Total100% (3/3)97.2% (70/72)40% (2/5)98.1% (53/54)